These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trafficking of immature DeltaF508-CFTR to the plasma membrane and its detection by biotinylation. Luo Y, McDonald K, Hanrahan JW. Biochem J; 2009 Apr 01; 419(1):211-9, 2 p following 219. PubMed ID: 19053947 [Abstract] [Full Text] [Related]
5. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator. Namkung W, Kim KH, Lee MG. Gastroenterology; 2005 Dec 01; 129(6):1979-90. PubMed ID: 16344066 [Abstract] [Full Text] [Related]
6. Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking. Gentzsch M, Choudhury A, Chang XB, Pagano RE, Riordan JR. J Cell Sci; 2007 Feb 01; 120(Pt 3):447-55. PubMed ID: 17213331 [Abstract] [Full Text] [Related]
10. Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule. Loo TW, Bartlett MC, Clarke DM. Biochemistry; 2009 Oct 20; 48(41):9882-90. PubMed ID: 19761259 [Abstract] [Full Text] [Related]
14. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound. Loo TW, Bartlett MC, Clarke DM. Mol Pharm; 2005 Oct 20; 2(5):407-13. PubMed ID: 16196493 [Abstract] [Full Text] [Related]